Interesting connection. Dr. Eric Topol, a profe
Post# of 148277
Quote:
Dr. Eric Topol, a professor of molecular medicine at Scripps Research and founder and director of the Scripps Research Translational Institute, said the new findings come in a “very interesting report that adds to the possible underpinnings of long COVID.”
https://fortune.com/well/2022/10/04/long-covi...oc43-pasc/
Quote:
"These findings suggest an unexpected alternative mechanism for #LongCovid. Rather than persistent immune activation, we observed abnormal immune downmodulation, which is normalized by leronlimab [a CCR5 antibody]"
https://twitter.com/EricTopol/status/15175909..._lNS4QcSAQ